Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 820,000 | 2,013,000 | 3,406,000 | 2,611,000 | 2,138,000 |
| Marketable Securities | 25,359,000 | 26,615,000 | 22,069,000 | 19,687,000 | 20,115,000 |
| Receivables | 10,245,000 | 10,432,000 | 9,843,000 | 9,942,000 | 9,497,000 |
| Inventories | 5,334,000 | 5,148,000 | 5,302,000 | 5,210,000 | 5,734,000 |
| Other current assets | 1,182,000 | 864,000 | 731,000 | 641,000 | 574,000 |
| TOTAL | $48,651,000 | $51,011,000 | $46,849,000 | $41,840,000 | $41,622,000 |
| Non-Current Assets | |||||
| PPE Net | 14,925,000 | 15,383,000 | 15,734,000 | 15,714,000 | 16,298,000 |
| Investments And Advances | 7,105,000 | 4,511,000 | 4,856,000 | 4,922,000 | 5,067,000 |
| Intangibles | 41,579,000 | 41,452,000 | 41,880,000 | 42,208,000 | 43,887,000 |
| Other Non-Current Assets | 4,255,000 | 6,193,000 | 5,949,000 | 4,346,000 | 3,529,000 |
| TOTAL | $67,864,000 | $67,539,000 | $68,419,000 | $67,190,000 | $68,781,000 |
| Total Assets | $116,515,000 | $118,550,000 | $115,268,000 | $109,030,000 | $110,403,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,448,000 | 8,909,000 | 5,825,000 | 2,645,000 | 2,432,000 |
| Accounts payable and accrued liabilities | 1,928,000 | 1,909,000 | 2,270,000 | 2,298,000 | 1,845,000 |
| Accrued Expenses | 1,640,000 | 1,622,000 | 1,974,000 | 1,628,000 | 1,573,000 |
| Other current liabilities | 7,100,000 | 8,020,000 | 8,223,000 | 7,489,000 | 6,760,000 |
| TOTAL | $23,193,000 | $21,682,000 | $21,835,000 | $14,328,000 | $15,136,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,246,000 | 8,143,000 | 7,314,000 | 6,041,000 | 5,777,000 |
| Other Non-Current Liabilities | 13,616,000 | 13,861,000 | 13,413,000 | 14,507,000 | 13,794,000 |
| TOTAL | $26,753,000 | $29,451,000 | $28,423,000 | $28,092,000 | $27,173,000 |
| Total Liabilities | $49,946,000 | $51,133,000 | $50,258,000 | $42,420,000 | $42,309,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,740,995 | 6,765,197 | 6,760,989 | 6,829,805 | 6,927,109 |
| Common Shares | 443,000 | 443,000 | 442,000 | 442,000 | 442,000 |
| Retained earnings | 50,912,000 | 52,436,000 | 49,660,000 | 51,063,000 | 50,304,000 |
| Other shareholders' equity | 2,603,000 | 1,420,000 | 1,842,000 | -381,000 | -374,000 |
| TOTAL | $66,569,000 | $67,417,000 | $65,010,000 | $66,610,000 | $68,094,000 |
| Total Liabilities And Equity | $116,515,000 | $118,550,000 | $115,268,000 | $109,030,000 | $110,403,000 |